Tag Archives: NASDAQ:VYGR

Oppenheimer Initiates a Buy Rating on Voyager Therapeutics (VYGR)

In a report released today, Jay Olson from Oppenheimer initiated coverage with a Buy rating on Voyager Therapeutics (VYGR – Research Report) and a price target of $26.00. The company’s shares closed last Monday at $12.62, close to its 52-week

Evercore ISI Keeps a Hold Rating on Voyager Therapeutics (VYGR)

Evercore ISI analyst Joshua Schimmer maintained a Hold rating on Voyager Therapeutics (VYGR – Research Report) on November 22 and set a price target of $18.00. The company’s shares closed last Monday at $14.26. According to TipRanks.com, Schimmer is a

Voyager Therapeutics (VYGR) Receives a Buy from Cowen & Co.

In a report released today, Phil Nadeau from Cowen & Co. maintained a Buy rating on Voyager Therapeutics (VYGR – Research Report). The company’s shares closed last Monday at $14.66. According to TipRanks.com, Nadeau is a 4-star analyst with an

Cowen & Co. Reaffirms Their Buy Rating on Voyager Therapeutics Inc (VYGR)

Cowen & Co. analyst Phil Nadeau maintained a Buy rating on Voyager Therapeutics Inc (VYGR – Research Report) today. The company’s shares closed last Monday at $15.40. According to TipRanks.com, Nadeau is a 3-star analyst with an average return of

Voyager Therapeutics Inc (VYGR) Gets a Buy Rating from Nomura

Nomura analyst Christopher Marai maintained a Buy rating on Voyager Therapeutics Inc (VYGR – Research Report) on August 9 and set a price target of $37. The company’s shares closed last Monday at $20.11. Marai observed: “Minor Tweaks Post-NBIX Collab.,

Voyager Therapeutics Inc (VYGR) Receives a Buy from H.C. Wainwright

In a report released today, Debjit Chattopadhyay from H.C. Wainwright maintained a Buy rating on Voyager Therapeutics Inc (VYGR – Research Report), with a price target of $26. The company’s shares closed on Friday at $20.53. Chattopadhyay noted: “Our current